| 摘要 |
A controlled-release pharmaceutical dosage component comprising a microencapsulated bronchodilator agent of the beta -adrenergic agonist type is prepared by organic phase separation. Pharmaceutical formulations containing these components exhibit prolonged bronchodilation with minimal cardiac stimulation.
|
